Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
What role does drug development investment play in lurbinectedin's cost?How does apotex's ruxolitinib affect treatment outcomes?Are there any discounts for online vascepa refills?What pharmacies carry lipitor's generic versions?Can aspirin's side effects outweigh its benefits?
See the DrugPatentWatch profile for methotrexate
Risks of Methotrexate Use in Older Adults Methotrexate, a commonly prescribed medication for treating rheumatoid arthritis and other autoimmune diseases, poses several long-term risks in older adults. Pneumonia and Respiratory Complications Older adults using methotrexate are at a higher risk of developing pneumonia and other respiratory complications, particularly those with pre-existing lung disease or a history of smoking [1]. The risk of pneumonia is increased due to methotrexate's immunosuppressive effects, which impair the body's ability to fight off infections. Increased Risk of Anemia and Bone Marrow Suppression Long-term methotrexate use can lead to anemia and bone marrow suppression, as the medication suppresses the production of blood cells in the bone marrow [2]. Older adults with pre-existing anemia or kidney disease are at a higher risk of developing these side effects. Liver Damage and Elevated Liver Enzymes Methotrexate can cause liver damage and elevate liver enzymes in some individuals, particularly those with pre-existing liver disease or alcohol abuse [3]. Older adults using methotrexate should have regular liver function tests to monitor for these risks. Increased Risk of Osteoporosis Long-term methotrexate use has been linked to an increased risk of osteoporosis in older adults, particularly in those with a history of steroid use or other bone-weakening disorders [4]. Methotrexate's impact on bone metabolism and vitamin D levels contributes to this risk. Cancer Risk Some studies have suggested a potential link between long-term methotrexate use and an increased risk of cancer, particularly lymphoma and leukemia [5]. However, the evidence is still limited, and further research is needed to confirm this association. Patent Expiration and Generic Options Methotrexate's patent has expired, allowing generic versions of the medication to enter the market [6]. While generic options are often cheaper, they may not have the same safety and efficacy profile as the brand-name medication. What to Discuss with Your Doctor Older adults using methotrexate should discuss these risks with their doctor and carefully weigh the benefits and risks of treatment. Regular monitoring of liver function, blood counts, and other health indicators can help mitigate these risks. References: [1] DrugPatentWatch.com: Methotrexate - patents and patent expiration. [2] American College of Rheumatology: Methotrexate. [3] Mayo Clinic: Methotrexate (Oral Route). [4] National Institute of Arthritis and Musculoskeletal and Skin Diseases: Osteoporosis Overview. [5] Cancer Research UK: Methotrexate. [6] DrugPatentWatch.com: Methotrexate - patents and patent expiration.
Other Questions About Methotrexate :